Bay Area's Guardant Health Just Snagged $360 Million to Create Cancer Blood Tests Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why Bluebird Bio Investors Aren't Singing the Blues December 12, 2017 FDA Just Rejected Eli Lilly, Incyte's Rheumatoid Arthritis Drug Baricitinib April 13, 2017 FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies September 6, 2017